Analysts Set Hims & Hers Health, Inc. (NYSE:HIMS) Price Target at $19.86
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has been given an average recommendation of “Moderate Buy” by the sixteen analysts that are presently covering the company, MarketBeat reports. Eight research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month […]
More Stories
Company Recalls Nearly 10 Million Pounds of Ready-to-Eat Meat, Poultry Over Listeria Risk
By Naveen Athrappully Oklahoma-based BrucePac is pulling millions of pounds of meat items from across the United States due to...
DeSantis, Florida Officials Issue Warnings to Would-Be Looters Ahead of Hurricane Milton
By Jack Phillips Officials in Florida issued stark warnings to would-be looters during Hurricane Milton that they could get shot...
Low Vitamin D Levels Linked to Slower Healing in Children’s Fractures
By George Citroner Research presented at the American Academy of Pediatrics (AAP) 2024 National Conference & Exhibition underscores the critical...
China Overproducing Lithium to Eliminate Rivals: US Official
By Catherine Yang Jose Fernandez, under secretary for economic growth, energy, and the environment at the U.S. Department of State,...
Appeals Court Lets Ohio Enforce Law Banning Foreign Nationals From Spending on Campaigns
By Zachary Stieber A federal appeals court on Oct. 8 enabled Ohio to enforce a law that bans foreigners from...
US Building Industry Struggling to Fill Available Skilled Worker Positions
By Mark Gilman The nation’s builders not only have to contend with the dilemma of high interest and insurance rates...